Guidance
LC16m8 (live-attenuated freeze-dried vaccinia) smallpox and mpox vaccine - Interim Guidance
This first version of the interim guidance is primarily intended for use by health authorities, health workers, and other stakeholders involved in mpox vaccination and logistics for the deployment of the LC16m8 mpox vaccine in the Democratic Republic of the Congo (DRC) and other countries, as relevant.
Authors
Languages
Publication year
2025
Type
Categories
Countries
Organisations
Tags
WHO Regions
Mpox-Policy
This resource appears in the following Hot Topic page:
The resource is included in the following table:
